Brought to you by 
Valeant Pharmaceuticals buys DermaTech Pty. Ltd. for A$19mm
02 Jan 2012
Executive Summary
Valeant Pharmaceuticals International (dermatology and neurology therapeutics) has acquired dermatology company DermaTech Pty. Ltd. for A$19mm ($12.2mm).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
Drug Delivery
- Topical Delivery
- Transdermal
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Valeant Pharmaceuticals buys DermaTech Pty. Ltd. for A$19mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice